André P, Descotes J, Simonet R, Evreux J C
Methods Find Exp Clin Pharmacol. 1984 Nov;6(11):695-9.
Inhibition of hepatic drug metabolizing enzymes is an important cause of clinically relevant drug interactions. A close correlation was found between influence of pentobarbital-induced sleeping time in outbred Swiss mice and hepatic drug metabolism in man for several established inhibitors, i.e. chloramphenicol, cimetidine, idrocilamide, isoniazid, metronidazole, miconazole and triacetyloleandomycin, and control drugs, i.e. baclofen, ranitidine and spiramycin. Provided that room temperature is carefully controlled, barbiturate sleeping time is a simple, inexpensive and reproducible predictive tool for the experimental detection of pharmacological agents likely to inhibit hepatic drug metabolism.
肝药酶抑制是临床相关药物相互作用的重要原因。对于几种已确定的抑制剂,即氯霉素、西咪替丁、伊曲酰胺、异烟肼、甲硝唑、咪康唑和三乙酰竹桃霉素,以及对照药物,即巴氯芬、雷尼替丁和螺旋霉素,发现远交群瑞士小鼠中戊巴比妥诱导睡眠时间的影响与人的肝药代谢之间存在密切相关性。如果室温得到仔细控制,巴比妥类睡眠时间是一种简单、廉价且可重复的预测工具,用于实验检测可能抑制肝药代谢的药物制剂。